Hinge Health (HNGE) Cost of Revenue (2024 - 2026)

Hinge Health has reported Cost of Revenue for 3 years, with the latest figure at $28.1 million in Q1 2026.

• Quarterly Cost of Revenue rose 19.0% year-over-year to $28.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $124.1 million (up 38.95% YoY) and the FY2025 annual result came in at $119.6 million, up 32.19% from the prior year.
• Cost of Revenue climbed to $28.1 million in Q1 2026 per HNGE's latest filing, from $26.7 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $41.3 million in Q2 2025 and troughed at $21.2 million in Q4 2024.
• A 3-year average of $26.7 million and a median of $25.1 million in 2025 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2025 and 2026: Cost of Revenue surged 78.11% in 2025, then gained 19.0% in 2026.
• Over 3 years, Cost of Revenue stood at $21.2 million in 2024, then advanced by 26.13% to $26.7 million in 2025, then advanced by 5.15% to $28.1 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $28.1 million, $26.7 million, and $28.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.